Home orphan
 

Keywords :   


Tag: orphan

a Norwood biotech gets first of three potential orphan drug designations

2015-06-13 17:54:32| Biotech - Topix.net

A 10-employee Norwood biotech has received the first of what it expects will be three orphan drug designations from the Food and Drug Administration for a drug it bought last year from a professor at UMass Medical Center in Worcester. Corbus Pharmaceuticals , which just started trading on the Nasdaq exchange in April, has been known among investors mostly for its plan to develop the drug to treat inflammation associated with cystic fibrosis which could potentially be used in conjunction with the suite of drugs being produced at Boston-based Vertex Pharmaceuticals .

Tags: potential drug biotech designations

 

Swedish Orphan Plunges After Talks End on Potential Takeover

2015-06-09 02:52:46| Appliances - Topix.net

Swedish Orphan Biovitrum AB fell as much as 19 percent after the maker of treatments for rare diseases said it ended talks on a possible takeover offer. The drugmaker, better known as Sobi, has held talks with potential buyers since last year, Bloomberg reported in April, citing people familiar with the matter.

Tags: end potential talks swedish

 
 

Morning Links: Orphan works. Fighting the bad guys. WiFi-powered camera and Big Brother.

2015-06-05 19:02:30| Wireless - Topix.net

The Report documents the legal and business challenges faced by good faith users who seek to use orphan works and/or engage in mass digitization projects. The TeleRead Take: Slow progress on this issue, but still, progress.

Tags: links big works bad

 

Alnylam Receives Orphan Drug Designation From The United States Food & Drug Administration For Revusiran, An Investigational RNAi Therapeutic For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

2015-06-03 06:41:56| drugdiscoveryonline Home Page

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced recently that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to revusiran, an investigational RNAi therapeutic, for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis)

Tags: united states united states food

 

FDA Grants Orphan Drug Designation For DCR-PH1, Dicerna's Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1)

2015-04-29 05:21:48| drugdiscoveryonline Home Page

Dicerna Pharmaceuticals, Inc., a leading developer of RNA interference (RNAi) therapeutics, recently announced that the U.S

Tags: type primary treatment drug

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] next »